|
Epithelial-Mesenchymal Transition
|
D058750 |
[Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition.
] |
|
Counseling
|
F02.784.176 |
|
|
Psychology, Applied
|
F02.784 |
|
|
Vomeronasal Organ
|
D019147 |
[An accessory chemoreceptor organ that is separated from the main OLFACTORY MUCOSA. It is situated at the base of nasal septum close to the VOMER and NASAL BONES. It forwards chemical signals (such as PHEROMONES) to the CENTRAL NERVOUS SYSTEM, thus influencing reproductive and social behavior. In humans, most of its structures except the vomeronasal duct undergo regression after birth.
] |
|
Chromosomes, Human, Pair 13
|
A11.284.187.520.300.370.375 |
|
|
Chromosomes, Human, 13-15
|
A11.284.187.520.300.370 |
|
|
Neuromuscular Blockade
|
D019148 |
[The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.
] |
|
Nutrition Surveys
|
E05.318.308.980.485 |
|
|
Bioreactors
|
D019149 |
[Tools or devices for generating products using the synthetic or chemical conversion capacity of a biological system. They can be classical fermentors, cell culture perfusion systems, or enzyme bioreactors. For production of proteins or enzymes, recombinant microorganisms such as bacteria, mammalian cells, or insect or plant cells are usually chosen.
] |
|
Neonatology
|
H02.403.670.400 |
|
|
Brain Stem Neoplasms
|
C04.588.614.250.195.411.100 |
|
|
alpha-Synuclein
|
D12.776.637.500 |
|
|
3-Hydroxybutyric Acid
|
D020155 |
[BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
] |
|
Appetite Stimulants
|
D019167 |
[Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.
] |
|
Antithrombin III Deficiency
|
D020152 |
[An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.
] |
|
Portasystemic Shunt, Transjugular Intrahepatic
|
D019168 |
[A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (JAMA 1995;273(23):1824-30)
] |
|
Delayed Emergence from Anesthesia
|
C23.550.767.137 |
|
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
|
D03.383.606.527 |
|
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
D019161 |
[Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.
] |
|
Glycerophospholipids
|
D10.570.755.375.760.400 |
|
